Timeline and Expected Results During Treatment
Early Treatment Response (Days 1-3)
When treatment begins during the initial tingling stage, you may notice the most significant benefits. Aciclovir tablets, available through EverydayMeds, work by inhibiting viral replication when taken as prescribed. Early intervention may prevent full blister development or reduce their size. The initial tingling, burning, or itching sensation might decrease within 24-48 hours of starting treatment. However, some progression to the blister stage may still occur even with prompt treatment.
Active Treatment Phase (Days 3-6)
During this stage, blisters typically form and may eventually rupture. Aciclovir cream applied every 4 hours can provide localised treatment alongside oral medication. The antiviral action continues working to limit viral spread to healthy cells. You might notice that blisters remain smaller than in previous untreated outbreaks, or that new blisters stop forming sooner than expected. Pain and discomfort may be reduced compared to untreated episodes, though some symptoms will likely persist.
Healing and Recovery (Days 6-10)
The crusting and healing phase typically begins earlier with appropriate treatment. Aciclovir tablets continue supporting the healing process by maintaining antiviral levels in your system. The scabbing phase may be shorter, and the risk of secondary bacterial infection could be reduced. Complete healing usually occurs within 7-10 days with treatment, compared to 10-14 days without intervention. Some individuals may experience faster recovery, particularly if treatment began very early.
Factors Affecting Treatment Outcomes
Several factors influence how well treatment works for cold sores. Starting aciclovir within the first 24 hours of symptoms typically provides the best results. Your immune system strength, stress levels, and overall health also impact recovery speed. Valaciclovir tablets, another option available through EverydayMeds, may offer more convenient dosing for some patients. Frequency of outbreaks, with some people benefiting from suppressive therapy, can be discussed with healthcare providers.
Managing Expectations
While antiviral treatments can improve outcomes, they don't cure the underlying HSV-1 infection. Most people experience reduced symptom severity and shorter outbreak duration with proper treatment. Some individuals may notice minimal improvement, particularly if treatment starts late in the outbreak cycle. Combining oral antivirals with topical treatments may provide additional benefits for symptom management. Regular hand hygiene and avoiding touching the affected area supports the healing process and prevents transmission.
